Detailed Narrative
Q1 FY27 Performance Driven by Flavours and Margin Expansion
S H Kelkar and Company Limited commenced FY27 with a strong performance, achieving a 14% year-on-year growth in consolidated revenue from operations to ₹662 crore. This robust top-line growth translated into a 21% increase in consolidated EBITDA to ₹89 crore, with the EBITDA margin expanding to 13.4% from 12.6% in the prior year's corresponding quarter. The Flavour segment was a key driver, contributing ₹112 crore in revenue, though management noted about ₹15 crore was due to order preponement. The company considers this a 'baseline normal quarter' and expects similar performance going forward⏳.
Strategic Investments in R&D and Global Expansion Continue
The company is actively investing in strengthening its R&D capabilities and expanding its global Creative Development Centers (CDC) network, particularly in new markets like Europe, USA, and UK. These investments, while incurring near-term costs, are deemed crucial for winning larger briefs and building differentiated positions across categories. The European business, which recently completed its Q1 capex of ₹25 crore, is expected to achieve a Return on Capital Employed (ROCE) of 17-18% in the longer term, with new initiatives in Germany, USA, and UK targeting EBITDA breakeven in their third year of operation.
Capital Allocation Focused on Capacity and Debt Reduction
Capital expenditure for Q1 FY27 included ₹25 crore for European operations, which are now complete. An additional ₹25 crore is planned for the Vanvate factory in Q2, with ₹50 crore earmarked for other India plants, including a potential ₹25 crore for Vashivali upgradation that might be deferred to Q1 FY28. Net debt increased by ₹65 crore to ₹852 crore as of June 2026, primarily due to strategic inventory buildup and capital deployment. Management anticipates debt levels to remain high in Q2 but expects a reduction of approximately ₹25 crore quarter-on-quarter starting from Q3 FY27.
Proactive Raw Material Management and Pricing Strategy
Despite ongoing raw material volatility, the company maintained stable gross margins through a favorable product mix and proactive raw material planning, securing 6 months of inventory visibility. This strategy enabled the company to successfully pass on cost inflation to over 95% of its clients, ensuring margin protection. For clients who were reluctant to accept price corrections, supplies were withheld until negotiations were completed, which contributed to the softness observed in the domestic fragrance sales for the quarter.
Global Ingredients Softness and Insurance Claim Update
The Global Ingredients business experienced a softer quarter, marked by lower demand in select export markets and direct impact from supply chain disruption🌐s. Management expects a recovery in this segment during the second half of FY27. Additionally, the company recognized an exceptional income of ₹30 crore from an insurance claim related to a fire incident. The claim process is progressing well, with an estimated ₹50-60 crore still pending, and full settlement is anticipated within the current financial year.